Relationship between preexisting anti-varicella-zoster virus (VZV) antibody and clinical VZV reactivation in hematopoietic stem cell transplantation recipients.

概要

論文の詳細を見る
Reactivation of latent varicella zoster virus (VZV), presenting as localized zoster or asdisseminated infection, is a common and potentially serious complication in hematopoieticstem cell transplantation (HSCT) recipients. We retrospectively studied anti-VZV IgGtiters by the immune adherence hemagglutination method after HSCT and VZV DNA byreal-time PCR during clinical VZV reactivation using cryopreserved serum samples. Nosignificant difference was found between anti-VZV titers in 13 patients with VZV infection(localized zoster in 11 patients and disseminated zoster in 2 patients) and those in 13subjects without VZV infection at each time point after HSCT. Pre-existing anti-VZV titersof disseminated zoster cases tended to be lower than those of localized zoster cases(P=0.10). Serum VZV-DNA copy numbers at onset of disseminated zoster cases tendedto be higher than those of localized zoster cases (P=0.09). A strong inverse correlationwas found between pre-existing anti-VZV titer and serum VZV-DNA at onset (r=-0.90,P=0.006). In HSCT recipients, pre-existing antibody does not prevent development ofVZV reactivation but may contribute to decreased viral load at onset, resulting in a mildclinical course.
the American Society for Microbiologyの論文